Life Biosciences Stock
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
Sign up today and learn more about Life Biosciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Life Biosciences Stock
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases. Developer of drugs designed to promote longevity and find treatments for age-related diseases. The company's drugs help to combat the eight pathways of age-related decline and it's work addresses health decline due to aging as a systemic breakdown of the body, rather than a series of isolated events and conditions, enabling senior citizens to tackle age-related diseases with a view to ultimately extending healthy life spans.
Funding History
| January 2019 | $50.0M |
|---|---|
| May 2020 | $74.8M |
| January 2022 | $82.0M |
Management
Chief Executive Officer
Mehmood Khan
CIO
Tristan Edwards
Head Of Research & Development
Joan Mannick
Board Member
Bracken Darrell
Head, Intellectual Property Strategy
Frances Toneguzzo
Press
fiercepharma - May, 9 2023
Forge fires up gene therapy production partnership with Life Biosciencesglobenewswire - Apr, 23 2023
Life Biosciences Presents Groundbreaking Data at ARVO Demonstrating Restoration of Visual Function in Nonhuman Primatesprnewswire - Jan, 5 2022
Life Biosciences, Leading Developer of Therapeutics for Aging-Related Diseases, Completes $82 Million Series C Financing Roundfiercebiotech - Apr, 23 2021
Startup aims to treat Alzheimer's by invigorating neurons' garbage-disposal abilitieschicagotribune - Sep, 23 2019
WeWork founder sounds bonkers, but he sure does love marijuanaEquityZen Recognized As:
